244 related articles for article (PubMed ID: 24459141)
1. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
Collins PE; Kiely PA; Carmody RJ
J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
[TBL] [Abstract][Full Text] [Related]
2. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
[TBL] [Abstract][Full Text] [Related]
3. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
Kohda A; Yamazaki S; Sumimoto H
J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.
Wu CL; Kandarian SC; Jackman RW
PLoS One; 2011 Jan; 6(1):e16171. PubMed ID: 21249144
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
6. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.
Wessells J; Baer M; Young HA; Claudio E; Brown K; Siebenlist U; Johnson PF
J Biol Chem; 2004 Nov; 279(48):49995-50003. PubMed ID: 15465827
[TBL] [Abstract][Full Text] [Related]
7. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
Watanabe N; Iwamura T; Shinoda T; Fujita T
EMBO J; 1997 Jun; 16(12):3609-20. PubMed ID: 9218802
[TBL] [Abstract][Full Text] [Related]
8. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
Mathas S; Jöhrens K; Joos S; Lietz A; Hummel F; Janz M; Jundt F; Anagnostopoulos I; Bommert K; Lichter P; Stein H; Scheidereit C; Dörken B
Blood; 2005 Dec; 106(13):4287-93. PubMed ID: 16123212
[TBL] [Abstract][Full Text] [Related]
9. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade.
Carmody RJ; Ruan Q; Palmer S; Hilliard B; Chen YH
Science; 2007 Aug; 317(5838):675-8. PubMed ID: 17673665
[TBL] [Abstract][Full Text] [Related]
11. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
12. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.
Kabuta T; Hakuno F; Cho Y; Yamanaka D; Chida K; Asano T; Wada K; Takahashi S
Biochem Biophys Res Commun; 2010 Apr; 394(3):697-702. PubMed ID: 20226764
[TBL] [Abstract][Full Text] [Related]
14. Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity.
Wang VY; Li Y; Kim D; Zhong X; Du Q; Ghassemian M; Ghosh G
Mol Cell; 2017 Aug; 67(3):484-497.e5. PubMed ID: 28689659
[TBL] [Abstract][Full Text] [Related]
15. Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.
Lin L; DeMartino GN; Greene WC
EMBO J; 2000 Sep; 19(17):4712-22. PubMed ID: 10970863
[TBL] [Abstract][Full Text] [Related]
16. Activation of oxidative stress-regulated Bcl-3 suppresses CTCF in corneal epithelial cells.
Wang Y; Lu L
PLoS One; 2011; 6(8):e23984. PubMed ID: 21912613
[TBL] [Abstract][Full Text] [Related]
17. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein.
Bourteele S; Oesterle K; Weinzierl AO; Paxian S; Riemann M; Schmid RM; Planz O
Cell Microbiol; 2007 Sep; 9(9):2202-17. PubMed ID: 17573907
[TBL] [Abstract][Full Text] [Related]
18. NFKB1: a suppressor of inflammation, ageing and cancer.
Cartwright T; Perkins ND; L Wilson C
FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
[TBL] [Abstract][Full Text] [Related]
19. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T
J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238
[TBL] [Abstract][Full Text] [Related]
20. BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit.
Li Z; Wang X; Yu RY; Ding BB; Yu JJ; Dai XM; Naganuma A; Stanley ER; Ye BH
J Immunol; 2005 Jan; 174(1):205-14. PubMed ID: 15611242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
